Related Experiment Video
Updated: Jan 1, 2026

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
Modulation of methotrexate-induced intestinal mucosal injury by dietary factors
T Higuchi1,2, M Yoshimura1,2, S Oka1,3,4
1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Abstract:
Methotrexate (MTX)-induced intestinal mucosal injury in animals has been studied to understand how MTX can cause gastrointestinal disorders, but the pathogenesis of gastrointestinal disorders is still uncertain. We have attempted to reveal how dietary factors influence intestinal toxicity due to MTX. Mice were fed normal chow (NC) or a high-fat high-sucrose diet (HFHSD) before oral administration of MTX. While MTX significantly decreased the survival rates of mice fed HFHSD, the intestinal epithelial injury was detected. MTX excretion in the feces of mice fed HFHSD was reduced. Change of diets between NC and HFHSD influences the survival. The survival rates of the mice fed a high-sucrose diet or control diet were higher than those fed HFHSD. Higher survival rates were observed in mice fed a high-fat high-sucrose diet modified (HFHSD-M) in which casein was replaced by soybean-derived proteins. The survival rates of mice treated with vancomycin were lower than those administered neomycin. Microbiome and metabolome analyses on feces suggest a similarity of the intestinal environments of mice fed NC and HFHSD-M. HFHSD may modify MTX-induced toxicity in intestinal epithelia on account of an altered MTX distribution as a result of change in the intestinal environment.
Insights
Dietary factors significantly impact methotrexate (MTX) toxicity. A high-fat, high-sucrose diet (HFHSD) reduced MTX excretion and survival, while diet modification improved outcomes, suggesting altered MTX distribution.
Area of Science:
- Gastroenterology
- Toxicology
- Microbiome Research
Background:
- Methotrexate (MTX) causes intestinal injury, but its exact pathogenesis remains unclear.
- Dietary influences on MTX-induced gastrointestinal toxicity are not well understood.
Purpose of the Study:
- To investigate how dietary factors influence MTX-induced intestinal toxicity.
- To elucidate the role of diet in MTX gastrointestinal disorders.
Main Methods:
- Mice were fed normal chow (NC) or a high-fat high-sucrose diet (HFHSD) before MTX administration.
- Survival rates, intestinal injury, and MTX fecal excretion were assessed.
- Microbiome and metabolome analyses were performed on fecal samples.
Main Results:
- MTX significantly decreased survival and increased intestinal injury in HFHSD-fed mice.
- MTX fecal excretion was reduced in HFHSD-fed mice.
- Diet modification (HFHSD-M) and specific antibiotics (neomycin) improved survival rates.
Conclusions:
- High-fat, high-sucrose diets exacerbate MTX-induced intestinal toxicity.
- Altered MTX distribution due to changes in the intestinal environment likely mediates this effect.
- Dietary interventions and microbiome modulation show potential for mitigating MTX toxicity.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Therapeutic Drug Monitoring: Affecting Factors
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors